SEREXIA

A few selected publications SEREXIA leadership authored

  1. A systematic review to summarize treatment patterns, guidelines, and characteristics of patients with renal cell carcinoma in the Asia-Pacific region.

So TH, Sharma S, Parij R, Spiteri C, Chawla E, Pandey P, et al. Expert Review of Anticancer Therapy. 2023;23(8):853-63.

Read More

  • Evaluation of Quality of Pharmacoeconomic Studies in Asia-Pacific Region and Identification of Influencing Variables.

Pandey P, Pandey RD, Shah V. Value in health regional issues.2018;15:70-5.
Read More

  • A systematic literature review of the epidemiology, clinical, economic and humanistic burden in recurrent respiratory papillomatosis.
    Ovcinnikova O, Engelbrecht K, Verma M, Pandey R, Morais E. Respiratory Research. 2024;25(1):430.
    Read More
  • Patient-reported outcome measurement and reporting for patients with advanced renal cell carcinoma: a systematic literature review.
    Motzer RJ, Rane PP, Saretsky TL, Pawar D, Nguyen AM, Sundaram M, et al. European Urology. 2023.
    Read More
  • Efficacy of Anti-Alzheimer’s (AD) Drugs in Cognitive Improvement: A Network Meta-Analysis (NMA) of Randomized Controlled Trials (RCTs).
    Pandey P, Pawar D, Dhayalan S, Pandey R. Value in Health. 2023;26(12):S30.
    Read More
  • Epidemiology, treatment patterns, and humanistic and economic burden of biliary tract carcinoma: A systematic and targeted literature review.
    Kamble S, Desai K, Joo S, Pandey P, Swami S, Habila M, et al. Journal of Clinical Oncology. 2024;42(3_suppl):443.
    Read More
  • Assessing the Epidemiology, Treatment Patterns, and Economic Impact of Marginal Zone Lymphoma: A Review of the Literature.
    Squires P, Saini P, Pandey P, Pandey R, Hall A, Ryland KE, et al. Blood. 2022;140(Supplement 1):11987–9.
    Read More
  • Indirect Treatment Comparison of SGLT2 Inhibitor Monotherapy in Patients with Uncontrolled Type 2 Diabetes on Diet/Exercise or Metformin.
    Pandey P, Pandey R, Dhagale P, Shah V. Value in Health. 2019;22:S142–3.
    Read More

About SEREXIA

SEREXIA is a healthcare analytics and consulting partner helping pharma, biotech, MedTech, and healthcare providers unlock smarter, evidence-based decisions.

Address
Mantri Commercio, No 51, 202/A Devarabeesanahalli, Bellandur, Bangalore South, Bangalore- 560103, Karnataka

Email: contact@serexia.com

© 2025 SEREXIA Consulting Pvt. Ltd. All rights reserved.

Scroll to Top